Go Pro
NASDAQ:BGLC

BioNexus Gene Lab Q4 2025 Earnings Report

BioNexus Gene Lab logo
$1.79 +0.06 (+3.46%)
As of 10:15 AM Eastern
This is a fair market value price provided by Massive. Learn more.

BioNexus Gene Lab EPS Results

Actual EPS
-$0.52
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

BioNexus Gene Lab Revenue Results

Actual Revenue
$0.48 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

BioNexus Gene Lab Announcement Details

Quarter
Q4 2025
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

BioNexus Gene Lab Earnings Headlines

Sell Tesla, Buy the New King of FSD Cars
In 2023, Marc Chaikin's system flagged an automotive stock as bearish - and it fell 35% shortly after. Today, that same stock has earned a 'Very Bullish' rating after forming a major partnership with Nvidia to power AI-driven autonomous vehicles. This barely-known company was selected to handle the complex job of getting Nvidia's self-driving AI safely inside vehicles - positioning it at the center of a massive trend most investors are still missing through Tesla.tc pixel
See More BioNexus Gene Lab Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BioNexus Gene Lab? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioNexus Gene Lab and other key companies, straight to your email.

About BioNexus Gene Lab

BioNexus Gene Lab (NASDAQ:BGLC), through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

View BioNexus Gene Lab Profile